CD86 and B-cell chronic lymphocytic leukemia: In the current study, CLL activation induced increased levels of both costimulatory (CD80, CD86) and co-inhibitory (CD274, CD276) molecules suggesting a capacity to either stimulate or suppress T cell responses.